OSE Immunotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference September 14 - 16, 2020 (Virtual ...
NANTES, France, Sept. 08, 2020 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced it will present at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held virtually on September …